NitriCap Medical
NitriCap Medical
  • Home
  • About Us
  • Meet Our Team
  • Our Technology
  • About Nitric Oxide
  • Market Need
  • News
  • Contact Us
  • More
    • Home
    • About Us
    • Meet Our Team
    • Our Technology
    • About Nitric Oxide
    • Market Need
    • News
    • Contact Us
  • Home
  • About Us
  • Meet Our Team
  • Our Technology
  • About Nitric Oxide
  • Market Need
  • News
  • Contact Us

NitriCap Catheter Insert Device

NitriCap is a single-use antimicrobial catheter insert device that uses breakthrough nitric oxide-eluting technology to fight catheter-related bloodstream infections.

How It Works

Tunneled Hemodialysis Catheters (TDC)

Tunneled Hemodialysis Catheters (TDC)

Tunneled Hemodialysis Catheters (TDC)

During an in-clinic dialysis session (3 times / week), caps to access each TDC lumen are removed for dialysis procedure access.

Infections & Dysfunction

Tunneled Hemodialysis Catheters (TDC)

Tunneled Hemodialysis Catheters (TDC)

Bacteria is most often introduced into TDC at hub. It then adheres to biofilm (a thin slimy film) or activated platelets (clots) inside TDC which lead to bloodstream infections.

NitriCap Placement

Tunneled Hemodialysis Catheters (TDC)

Proprietary Chemistry

NitriCap inserts are secured into catheter hub and remain in place between hemodialysis treatments.

Proprietary Chemistry

Proven Antibacterial Efficacy

Proprietary Chemistry

Once inserted, NitriCap's patent-pending technology releases precise quantities of nitric oxide into catheter hub to kill bacteria, disperse biofilm, and inhibit platelet aggregation.

Learn more about nitric oxide

Proven Antibacterial Efficacy

Proven Antibacterial Efficacy

Proven Antibacterial Efficacy

In vivo large animal studies show NitriCap reduces bacteria colony-forming units (CFU) by 10,000 fold as compared to the leading competitor throughout catheter.

Expansive Platform Technology

Proven Antibacterial Efficacy

Proven Antibacterial Efficacy

NitriCap's breakthrough technology can reduce bloodstream infections across other infusion catheter segments with a total market opportunity of over $900M.

For investigational use only. Not available for commercial sale

Copyright © 2022 NitriCap Medical Inc. - All Rights Reserved.